InvestSMART

Medibio Limited (ASX: MEB) - Announcements

- Current share price for MEB : $0.001

ASX company news and announcements for Medibio Limited (MEB) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Medibio Limited (MEB) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Medibio Limited (MEB), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Medibio Limited (MEB)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$6 Appendix 4C - quarterly & activities report 2 May 2016 8:05AM $0.245 $0.001 fallen by 99.59%
$6 Disclosure Document - Notice under Section 708A 29 Apr 2016 5:48PM $0.245 $0.001 fallen by 99.59%
$6 Appendix 3B 29 Apr 2016 5:45PM $0.245 $0.001 fallen by 99.59%
$6 Medibio Shareholder Newsletter 21 Apr 2016 10:27AM $0.210 $0.001 fallen by 99.52%
$6 Medibio Acquires Key IP 19 Apr 2016 9:45AM $0.235 $0.001 fallen by 99.57%
$6 Appendix 3B - release of Escrow 8 Apr 2016 3:29PM $0.230 $0.001 fallen by 99.57%
$6 Presentations for investor briefings commencing 5 April 4 Apr 2016 1:39PM $0.235 $0.001 fallen by 99.57%
$6 Successful Pre-Submission Meeting with the US FDA 1 Apr 2016 9:39AM $0.225 $0.001 fallen by 99.56%
$6 Release of escrow shares 21 Mar 2016 4:28PM $0.195 $0.001 fallen by 99.49%
$6 Presentation to BioMelbourne Conference on Wireless & Wearab 17 Mar 2016 9:53AM $0.220 $0.001 fallen by 99.55%
$6 4 leading US Institutions provide Medibio 10,000 data sets 11 Mar 2016 12:52PM $0.195 $0.001 fallen by 99.49%
$6 Swinburne Software Labs trial success with Apple Watch & FIT 8 Mar 2016 11:32AM $0.200 $0.001 fallen by 99.50%
$6 Half Yearly Report and Accounts 26 Feb 2016 7:26PM $0.250 $0.001 fallen by 99.60%
$6 First Wellness Channel Partner commercial pilot commenses 16 Feb 2016 9:41AM $0.210 $0.001 fallen by 99.52%
$6 Partnership to evaluate wearable applications for Mental Hea 9 Feb 2016 10:34AM $0.240 $0.001 fallen by 99.58%
$6 Disclosure Document - S708A Notice 8 Feb 2016 7:29PM $0.250 $0.001 fallen by 99.60%
$6 Replacement Appendix 3B 8 Feb 2016 7:26PM $0.250 $0.001 fallen by 99.60%
$6 Replacement Appendix 3B 1 Feb 2016 8:23AM $0.250 $0.001 fallen by 99.60%
$6 Appendix 4C - quarterly 1 Feb 2016 8:23AM $0.250 $0.001 fallen by 99.60%
$6 Initial Director's Interest Notice 29 Jan 2016 7:39PM $0.250 $0.001 fallen by 99.60%
$6 Appendix 3B 29 Jan 2016 7:37PM $0.250 $0.001 fallen by 99.60%
$6 Highly distinguished US Medical expert appointed Director 27 Jan 2016 10:34AM $0.260 $0.001 fallen by 99.62%
$6 Receipt of R&D Tax Incentive Refund 14 Jan 2016 10:05AM $0.300 $0.001 fallen by 99.67%
$6 Agreement takes Medibio's stress diagnostic to Saudi Arabia 23 Dec 2015 10:43AM $0.310 $0.001 fallen by 99.68%
$6 MEB signs MOU with $100 billion NYSE listed medical company 22 Dec 2015 10:05AM $0.290 $0.001 fallen by 99.66%

551 - 575 of 620 results

Page 23 of 25

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.